2021
## Burma Skincare Initiative
## REPORT AND UNAUDITED ACCOUNTS
## Contents
|Trustees’ Report and Financial Statements for the period to 31 March 2021|2|
|---|---|
|Objectives and Activities of the Burma Skincare Initiative|3|
|Structure Governance and Management|5|
|Statement of Trustees’ responsibilities|6|
|Independent Examiner’s Report|7|
|Receipts and Payments Accounts|8|
1
Trustees’ Report and Financial Statements for the period to 31 March 2021
Registered Charity Number 1187197
Principal Office:
4 Fitzroy Square London W1T 5HQ
Trustees at the date this report was approved Professor Christopher Griffiths (Chair) Stephen Lue Dr Su Lwin
Bankers NatWest plc
Independent Examiner Delta Solutions 3 Wellgreen Close Hale Altrincham WA15 8PT
2
## Objectives and Activities of the Burma Skincare Initiative
## Overview
The Burma Skincare Initiative (BSI) is a small charity, founded in 2020, that has as its overarching mission the promotion of skincare excellence for the people of Burma (Myanmar). A particular focus is on skincare provision to the disadvantaged people of Burma. It is an active and sustainable collaboration between dermatologists and dermatology nurses based predominantly in the UK with their colleagues in Burma. The BSI’s strategy is founded on the three pillars of: education, research and clinical care articulated via a 10-year strategic plan focused on short, medium and long-term goals.
## Objectives and Activities of the BSI
The BSI has the following objectives:
## Short-term:
To run an inaugural BSI dermatology meeting in Yangon, Burma (Myanmar). Establish travel and exchange fellowships for doctors and nurses and virtual case conferences. To set up research studies on diagnosis and management of mycetoma. To establish a fully functional website for the charity.
## Medium-term:
To provide regular BSI meetings and training in diagnosis and management of skin disease by community nurses and healthcare workers in township hospitals with aid of educational videos and teledermatology. To design and run a skin disease survey in Burma and to establish a diagnostics service for immune-bullous diseases. To work with colleagues to establish rural skincare clinics.
## Long-term:
To establish a regional dermatology training and research centre in Burma
## Achievements and Performance
In the reporting year from inception of the charity on 3 January 2020 to 31 March 2021 the BSI attained some important objectives from its short-term strategic goals.
As one of the optimistic first steps in achieving the BSI goals, it was proposed to hold annual BSI educational meetings as a platform for Myanmar and international dermatology communities to exchange knowledge and experience on the management of, and the latest research in, common and rare skin diseases for mutual benefit. Furthermore, networking opportunities would enable local and international dermatologists to work together to conduct crucial research such as understanding the prevalence of skin disease in Myanmar and to address the long-term sustainable goals of the BSI. These meetings could be realised by collaboration with partners from industry and non-governmental organisations (NGOs), such as Medical Action Myanmar.
An immense international effort and overwhelming enthusiasm from UK dermatologists and dermatology nurses and crucial buy-in from the Myanmar medical and nursing communities, supported by the British Association of Dermatologists (BAD), British Dermatological Nursing Group (BDNG), and the three dermatology centres in Myanmar, the BSI organised
3
`–` the first international dermatology meeting in Yangon, Myanmar on 21 24 February 2020 (www.bsi2020.com). The meeting was attended by more than 70 nurses and 200 dermatologists, General Practitioners and physicians from across Myanmar, and was a resounding success, academically, socially and culturally. The first day of the meeting was devoted to dermatology nursing whilst the second and third days – the main meeting - were developed specifically for Myanmar dermatologists, consisting of plenary lectures by eminent international speakers from the UK and Germany, important presentations by Myanmar dermatologists, and oral and poster presentations by Myanmar and UK dermatology trainees. The day after the meeting was devoted to a roundtable of stakeholders in skincare in Burma including nurses and dermatologists from the UK and Burma and representatives of the Tropical Health Education Trust and the Royal College of Physicians (London). This enabled a firming up of the charity’s strategic plan.
Other key achievements in the reporting year included the establishment of two fellowships for dermatologists from Burma to attend (virtually) the meetings of the International Society for Atopic Dermatitis and the British Society for Paediatric Dermatology. We are most grateful to these organisations for their support of the BSI.
Inevitably, two factors limited any significant achievements in the reporting period namely Covid-19 (see below) and the military coup in Burma that occurred on 1 February 2021
## Covid-19 statement
The spread of Covid-19 into Burma in late February 2020 curtailed any on the ground activities by the BSI team. During the time that dermatologists in Burma were able to continue daily practice, we were in active communication with them in 2020.
4
## Structure Governance and Management
## Trustees during the year covered by this report
Professor Christopher Griffiths (Chair), Stephen Lue and Dr Su Lwin all are founder trustees of the charity
The current Trustees and their areas of responsibility are given below:
Professor Christopher Griffiths (Chair) Stephen Lue (Trustee) Dr Su Lwin (Trustee)
## Governance
The Trustees have developed:
- a vision and mission statement for the BSI;
- a robust policy framework including policies on:
- Risk Management
- Investment
- Safeguarding vulnerable beneficiaries
- Conflicting Interests
- Complaint Handling
- a five-year business plan;
- a strategic plan for the next 10 years; and
- a Trustee register of skills and interests.
The Trustees receive regular formal training on their responsibilities.
The Trustees have overall responsibility for the day-to-day management of the BSI and meet regularly to discuss matters and to make decisions affecting the charity.
A risk assessment has been prepared and reviewed by the Trustees. Policies and procedures have been formalised so that any risks can be identified, actively managed and where possible, mitigated.
5
## Statement of Trustees’ responsibilities
In the attached accounts set out on pages 8 to 9, the Trustees have prepared financial statements for the period up to 31 March 2021. In preparing such statements the Trustees are required to:
- select suitable accounting policies and apply them consistently.
- make judgements and estimates that are reasonable and prudent;
- state whether applicable accounting standards and statements of recommended practice have been followed, subject to any departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume the Foundation will continue in its operational existence.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at the time the financial position of the Foundation and to enable them to ensure that the financial statements comply with the Charities Act 2011. They are also responsible for safeguarding the assets of the Foundation and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The report was approved by the trustees on 30 January 2022 and signed on its behalf by:
Professor Christopher Griffiths Chair
Dr Su Lwin Trustee
6
## **Independent Examiner’s Report**
|**Report to the trustees/**
**members of**
**On accounts for the**
**period**
**Set out on pages**|Burma Skincare Initiative|Burma Skincare Initiative|Burma Skincare Initiative|
|---|---|---|---|
|||||
||3 January 2020 to 31 March 2021|**Charity no**
**(if any)**|1187197|
|||||
||8 to 9|||
I report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the period ended 31/03/2021.
- **Responsibilities and** As the charity trustees of the Trust, you are responsible for the preparation **basis of report** of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).
I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
**Independent** I have completed my examination. I confirm that no material matters have **examiner's statement** come to my attention in connection with the examination which gives me cause to believe that in, any material respect:
- accounting records were not kept in accordance with section 130 of the Act or
- the accounts do not accord with the accounting records
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached.
|**Signed:**
**Name:**
**Relevant professional**
**qualification(s) or body**
**(if any):**
**Address:**
|S Weighell (Jan 31, 2022 10:44 GMT)
S Weighell|Jan 31, 2022|
|---|---|---|
||||
||Susan Weighell||
||||
||FCA||
||||
||3 Wellgreen Close, Hale||
||Altrincham||
||WA15 8PT||
7
## **Burma Skincare Initiative**
## **1187197**
## **Receipts and payments accounts**
~~**For the**~~
**To period from 03/01/2020 31/03/2021**
## **Section A Receipts and payments**
|**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**
**30,774**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**30,774**
**-**
**-**
**-**
**30,774**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**30,774**
**-**
**-**
**30,774**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Total funds**
**to the nearest £**
**30,774**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**30,774**
**-**
**-**
**-**
**30,774**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**30,774**|**Total funds**
**to the nearest £**
**30,774**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**30,774**
**-**
**-**
**-**
**30,774**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**30,774**|**Last year**
**to the nearest £**|
|---|---|---|---|---|---|---|
|Donations|**30,774**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_
_AR)_|**30,774**|||||**-**|
||||||||
|**A2 Asset and investment sales,**
**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_**
**A3 Payments**|||||||
|||||||**-**|
||||||||
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
||||||||
|**A4 Asset and investment**
**purchases (see table)**|||||||
|**,**|**-**||||||
||**-**||||||
|**_Sub total_**|**-**|||||**-**|
|**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||
|||||||**-**|
||||||||
||**30,774**|**-**|**-**|**30,774**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**30,774**|**-**|**-**|**30,774**||**-**|
8
|**Section B Statement of assets and liabilities at**|**Section B Statement of assets and liabilities at**|**the end of the period**||
|---|---|---|---|
|**Categories**
Signed on behalf of all the trustees
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**
**B5 Liabilities**
**B3 Investment assets**|Signature
**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
Bank account
**Details**
**Details**
Su Lwin (Jan 31, 2022 10:20 GMT)|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**30,774**
**-**
**-**
**-**
**-**
**-**
**30,774**
**-**
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Professor Christopher Griffiths
Dr Su Lwin|**Endowment**
**funds**
**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Endowment**
**funds**
**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**
**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**
**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**
**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of
approval|
|||Professor Christopher Griffiths|30/01/2022|
||Su Lwin (Jan 31, 2022 10:20 GMT)|Dr Su Lwin|30/01/2022|
9
2022-01-31
Final Audit Report
## BSI Final Report 2021
Created: 2022-01-31 By: Sue Weighell (sue@delta-solutions.org.uk) Status: Signed Transaction ID: CBJCHBCAABAA-OAwioQZnW6oUmH8fPy15u392pl33E9U
## "BSI Final Report 2021" History
## Document created by Sue Weighell (sue@delta-solutions.org.uk)
2022-01-31 - 8:41:26 AM GMT- IP address: 86.144.0.135
## Document emailed to Christopher Griffiths (christopher.griffiths@manchester.ac.uk) for signature
2022-01-31 - 8:44:59 AM GMT
## Email viewed by Christopher Griffiths (christopher.griffiths@manchester.ac.uk)
2022-01-31 - 8:45:22 AM GMT- IP address: 90.203.62.218
## Document e-signed by Christopher Griffiths (christopher.griffiths@manchester.ac.uk)
Signature Date: 2022-01-31 - 9:57:01 AM GMT - Time Source: server- IP address: 90.203.62.218
## Document emailed to Su Lwin (su.m.lwin@kcl.ac.uk) for signature
2022-01-31 - 9:57:03 AM GMT
Email viewed by Su Lwin (su.m.lwin@kcl.ac.uk)
2022-01-31 - 10:19:33 AM GMT- IP address: 85.255.234.56
## Document e-signed by Su Lwin (su.m.lwin@kcl.ac.uk)
Signature Date: 2022-01-31 - 10:20:31 AM GMT - Time Source: server- IP address: 85.255.234.56
Document emailed to S Weighell (accounts@delta-solutions.org.uk) for signature 2022-01-31 - 10:20:33 AM GMT
Email viewed by S Weighell (accounts@delta-solutions.org.uk)
2022-01-31 - 10:43:47 AM GMT- IP address: 86.144.0.135
## Document e-signed by S Weighell (accounts@delta-solutions.org.uk)
Signature Date: 2022-01-31 - 10:44:18 AM GMT - Time Source: server- IP address: 86.144.0.135
## Agreement completed.
2022-01-31 - 10:44:18 AM GMT